Cooke & Bieler LP grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 18.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,061,910 shares of the medical instruments supplier's stock after purchasing an additional 1,092,922 shares during the period. DENTSPLY SIRONA makes up approximately 2.2% of Cooke & Bieler LP's investment portfolio, making the stock its 7th largest holding. Cooke & Bieler LP owned 3.33% of DENTSPLY SIRONA worth $251,333,000 as of its most recent filing with the SEC.
A number of other large investors also recently modified their holdings of XRAY. VisionPoint Advisory Group LLC grew its holdings in DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 395 shares during the period. Point72 Asset Management L.P. acquired a new position in DENTSPLY SIRONA during the second quarter worth about $44,000. Parkside Financial Bank & Trust grew its holdings in DENTSPLY SIRONA by 163.7% during the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier's stock worth $46,000 after acquiring an additional 568 shares during the period. Anchor Investment Management LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter worth about $47,000. Finally, Exchange Traded Concepts LLC grew its holdings in DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier's stock worth $51,000 after acquiring an additional 439 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the company. Barrington Research reaffirmed an "outperform" rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a report on Thursday. Piper Sandler increased their price target on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a "neutral" rating in a research report on Friday, January 12th. SVB Leerink assumed coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an "outperform" rating and a $42.00 price target for the company. Needham & Company LLC reiterated a "buy" rating and issued a $42.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Finally, Leerink Partnrs reiterated an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $39.50.
View Our Latest Stock Report on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Up 0.2 %
NASDAQ XRAY traded up $0.06 during trading on Friday, reaching $30.50. 1,843,773 shares of the company's stock were exchanged, compared to its average volume of 4,579,977. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.27 and a fifty-two week high of $43.24. The firm has a market capitalization of $6.32 billion, a PE ratio of -49.19, a P/E/G ratio of 1.23 and a beta of 0.98. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. The company's fifty day simple moving average is $32.79 and its 200-day simple moving average is $32.84.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business's quarterly revenue was up 3.0% compared to the same quarter last year. During the same period last year, the company posted $0.46 EPS. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.
DENTSPLY SIRONA Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.10%. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA's payout ratio is currently -103.22%.
About DENTSPLY SIRONA
(Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- Using the MarketBeat Dividend Tax Calculator
- MarketBeat Week in Review – 4/15 - 4/19
- Quiet Period Expirations Explained
- Comprehensive Analysis of PayPal Stock
- Intuitive Surgical Stock Can Trend Much Higher This Year
→ Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad)
Should you invest $1,000 in DENTSPLY SIRONA right now?
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Metaverse Stocks And Why You Can't Ignore Them
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
